Elaine V. Jones, Director at CytomX Therapeutics, Inc. (CTMX), bought 5,000 shares at $1.55 ($8K) on 2023-03-29, disclosed to the SEC on 2023-03-31.
Open-market purchase of $8k CTMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.